We evaluated 203 heal thy pre-school chi1 dren between the ,ages o f 44 and 54 during 1 week i n March. Using anthropologists calipers, maximum head lengths (glabella t o opisthocranium) and the maximum head breadth (euryon t o euryon) were measured. A second i n v e s t i g a t o r performed tympanometry. Neither investigator knew the o t h e r ' s r e s u l t s when assessing a subject. Cephalic index (CI) = Maximum head breadth x 100 Mean = 76.1 SD + 3.7 head length Children were considered brachycephalic whose CI>79.8 (+I SD), those with' a C I between 72.4 and 79.8 were mesoce4ja;oc. and those w i t h a CI< 72.4 (-1 SD) were considered dolichocephalic. A tympanometry f a i l u r e was defined as a Jerger's Type B tympanogram i n one o r both ears. x2 = 6.2 p < .05
Brachycephalic children were also found t o have s i q n i f i c a n t l y more effusions than meso-and dolichocephalic children considered together (~( 0 . 0 5 ) . Apache Indians are brachycephalic people (CI = 90) and have poor ET function, as i s the case w i t h those having Down's syndrome. It i s possible t h a t brachycephaly ref l e c t s an anatomical v a r i a t i o n i n the cranial base which, i n turn, predisposes t o poor ET function & middle ear pathology. .' of Neurology and Pediatrics, Farmington, CT Zinc is essential for normal embryonic growth and differentiation. A high rate of fetal neural tube defects occurs in pregnancies of women with untreated acrodermatitis enteropathica and in experimental gestational zinc deficiency in rats; however, serum zinc is normal in children with spina bifida and in mothers of anencephalics during gestation. Confluent cultures of skin fibroblasts from two term newborns with anencephaly and lumbar meningomyelocele and three age-matched controls were studied in triplicat in six experiments. 65Znc12 (2 pCi. 55 nM Zn*, 2 x 103 cells) was added in fresh media (10% horse serum) and co nted in whole washed cell suspensions at 24 hours. 6YZn uptake was significantly (p < .001) lower in the infants with neural tube defects (281 f9.5 cpm/pg DNA) compared to controls (382 t 5 0 . 7 ) .
DEPRESSED CELLULAR ZINC UPTAKE IN ANENCEPHALY
The rate of zinc uptake was repeatable in each cell line. These results may reflect an abnormality of cellular zinc metabolism in infants with neural tube defects. We postulate that depressed embryonic uptake of zinc, perhaps due to heritable regulatory mechanisms, limits cellular differentiation during critical periods and thereby contributes to defective CNS formation. Terbutaline (T) a @2-sympathomimetic, has been extensively used; as a tocolytic agent in premature labor. To assess the influence of f eta1 P2-sympathomimetic stimulation upon glycemic (G) and calcemic (Ca) status, we compared the offspring of 12 women who had received T with 12 age and weight-matched infants of untreated mothers. Umbilical cord serum cortisol (F), insulin (I), growth hormone (GH), parathyroid hormone (PTH), calcitonin CCT) and glucagon (GLC) were measured by RIA. Mean' GA at onset of T was 30.7 wks; 69% were treated for less than 48 hrs. Mean time from last dose of T was 6.7 hours. Age, weight and hormone data are listed below: means C+SE) do not differ.
NEONATOLOGY
wk ~t(kg) G PTH CT I GLC GH F T-RX W 1 . 8 3 18810.4 Z F E 7 0 . 3 9 9 x . 2 3.1
(n-12) 20.6 +0.2 225 5 . 4 211 9 . 6 5 . 8 224.6 55.6 50.8 controls 34.3 7.20 161 10.3 27 76 12.7 109 26.5 3.0 (n=12) +0.4 9 . 1 215 5 . 3 514 5 1 +3.1 222 +6.6 5 . 2 At 24 hours, serum Ca was lower (p(0.02)in T-treated (7.420.3) than in control babies (8,520.3). Previously reported &agonist-induced neonatal hypoglycemia was not demonstrated, presumably prevented by glucose infusions. In conclusion: 1) Differences did not exist in cord glucose, calcium and hormone levels. 2) Ttreated offspring showed significant lowering of postnatal Ca, possibly due to exaggerated neonatal hypoparathyroidism secondary to adrenergic stimulation of maternal parathyroid glands. The influence of NEC on growth and gastrointestinal (GI) function, was determined at 1 year of age in 9 premature infants (MeanSD birthweight=1.45+.33 kg and gestational age=31.4+3 wks.) who had radiologically confirmed NEC. Seven of these infants were treated medically and 2 required surgery, (1 for prox. jejunal resection; 1 for post NEC colonic stenosis). Nine infants of similar weight and gestation were used as controls.
EFFECTS OF INSPIRATORY LOADING ON VENTILATION IN IN-

FANTS RECOVERING FROM RESPIRATORY DISTRESS SYNDROME (RDS
Mean + SD discharge age for controls=23.4t32 days and for study group 59240 days. Both groups had comparable dietary history since discharge. Followup at mean + SD 1322 months showed that both groups had similar weight, height and head circumference (50-85%ile) and similar mid-arm circumference and skinfold thickness (50-85Xile). Serum iron, albumin, pre-albumin, retinol binding protein, liver function studies and hematocrit were normal in both groups. Mean increment in serum vit. E levels 4 hrs. after an oral dose of 25 mg/kg vit. E was comparable for both groups (mean 0.3 vs. 0.34 mg/dl). Lactose malabsorption load (2 mg/kg) determined by hydrogen excretion was present in 219 control infants and 119 post NEC infants. This preliminary report suggests that in the absence of significant small bowel resection there is no detectable long term effect on nutritional status and GI function in infants who have recovered from NEC in the neonatal period. The pharmacokinetics of Phenobarb and Phenytoin were evaluated in 14 neonatal patients. The average gestational age at birth was 32 (25) weeks range, 26-41 weeks. The average post-conceptual age was 33 (26) weeks, range 26-44. The average weight was 1.67 (5.05) Kg, range 0.72-4.48. The patients were randomized as to which drug they would receive first. The drug was administere? as a 20mg/~g IV loading dose. If the first drug administered did not control the seizures, the second drug was given. Maintenance therapy was not begun, and serum levels were obtained at 2 hours, 12 hours, then every 12 hours after the dose until the phenytoin concentration was <10ug/ml and the phenobarbital concentration was <17ug/ml. At this point maintenance therapy was begun.
The average phenobarbital t)i was 173.0 (569.3) hours, range 28.2-607.8. The volume of distribution for phenobarbital was 0.84(20.26) 1/Kg, range 0.24-1.20. The average phenytoin t)i = 100.1 (512.1) hours, range 24.2-370.8. The volume of distribution for phenytoin was 1.58 (+0.54)1/Kg, range 1.03-3.24.
From this data, it would appear that a 25-30mg/Kg loading dose of either drug would produce serum levels in the middle to upper part of the therapeutic range. The calculated values are 30-36ug/ml for phenobarbital, and 16-19ug/ml for phenytoin.
